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The PI3K-Akt-mTORC1 axis contributes to the
activation, survival, and proliferation of CD4+ T cells
upon stimulation through TCR and CD28. Here, we
demonstrate that the suppression of this axis by
deletion of p85a or PI3K/mTORC1 inhibitors as well
as T cell-specific deletion of raptor, an essential
component of mTORC1, impairs Th17 differentiation
in vitro and in vivo in a S6K1/2-dependent fashion.
Inhibition of PI3K-Akt-mTORC1-S6K1 axis impairs
the downregulation of Gfi1, a negative regulator of
Th17 differentiation. Furthermore, we demonstrate
that S6K2, a nuclear counterpart of S6K1, is induced
by the PI3K-Akt-mTORC1 axis, binds RORg, and
carries RORg to the nucleus. These results point
toward a pivotal role of PI3K-Akt-mTORC1-S6K1/2
axis in Th17 differentiation.INTRODUCTION
Adaptive immune responses are accompanied by the differenti-
ation of several subsets of CD4+ T helper (Th) cells with distinct
cytokine expression profiles. The best known of these are Th
type 1 (Th1) and Th2 cells (Mosmann and Coffman, 1989).
Recent studies have identified IL-17 secreting Th (Th17) cells
as a third CD4+ subset characterized by the production of
IL-17A, IL-17F, IL-21, IL-22, and IL-10 (McGeachy and Cua,
2008). Th17 cells are involved in neutrophil-mediated inflamma-
tion and combat microbes attacking epithelial layers. Th17 cells
also playmajor roles in the pathophysiology of chronic inflamma-
tion observed in rheumatoid arthritis, psoriasis vulgaris, multiple
sclerosis, or inflammatory bowel disease in both human and
mouse (Ouyang et al., 2008).360 Cell Reports 1, 360–373, April 19, 2012 ª2012 The AuthorsThe differentiation of Th cells is determined by defined cyto-
kine milieus that induce characteristic transcription factors for
each Th subset (Dong, 2006). The differentiation of Th17 cells
requires both TGF-b and IL-6 inmice. TGF-b induces the expres-
sion of RORg, a critical transcription factor for the initiation of
Th17 differentiation (Ivanov et al., 2006), and inhibits the expres-
sion of Gfi1, which negatively regulates Th17 differentiation
(Ichiyama et al., 2009; Zhu et al., 2009). Although TGF-b also
induces the expression of Foxp3, which antagonizes the function
of RORg, IL-6 plays a pivotal role in downregulating the Foxp3
expression, thus promoting Th17 differentiation (Ichiyama
et al., 2008; Zhou et al., 2008). IL-21 and IL-1b play important
roles in the proliferation of Th17 cells (Gulen et al., 2010; Nurieva
et al., 2007). Furthermore, the activation of Th17 cells by IL-23
is a pivotal step for the development of chronic inflammation
(McGeachy et al., 2009).
Members of the phosphoinositide 3-kinase (PI3K) family are
important for the differentiation, proliferation, and survival of a
variety of cells, including immune cells (Koyasu, 2003). The basic
activity of these enzymes is to phosphorylate the third position of
the hydroxyl group in the inositol ring of phosphatidylinositol.
There are four subclasses of the PI3K family; among these, class
IA PI3K, composed of a catalytic subunit (p110a, b, or d) and
a regulatory subunit (p85a, p55a, p50a, p85b, or p55g), works
downstream of receptors such as T cell receptor (TCR) and
CD28 in T cells whose signaling pathways involve protein
tyrosine kinases and Ras. We have previously reported the
importance of class IA PI3K in B cell development, activation,
and IgE production (Doi et al., 2008; Suzuki et al., 1999, 2003).
PI3K signaling through mammalian target of rapamycin complex
1 (mTORC1) consisting of mTOR, raptor, and mLST8 regulates
the nuclear translocation of IRF7 for the production of type I
interferon (IFN) in plasmacytoid dendritic cells (Cao et al.,
2008). Production of IL-12 and IL-10 in conventional dendritic
cells is regulated by molecules downstream of PI3K, including
mTORC1 and GSK3b (Ohtani et al., 2008; Weichhart et al.,
Figure 1. Inhibiting Class IA PI3K Activity
Has Little Effect on Th1 and Th2 Differentia-
tion
(A) Immunoblot analysis of Akt phosphorylation
and band-shift assay of S6K1. Naive CD4+ T cells
were rested on ice or cultured with the indicated
combinations of immobilizedanti-CD3εAb, 1 mg/ml
soluble anti-CD28 Ab, and indicated inhibitors for
30 min, and total cell lysates were examined by
western blotting with the indicated Abs.
(B and C) Intracellular staining of IFN-g or IL-4 by
p85a+/ or p85a/ CD4+ T cells (B) or wt CD4+
T cells with or without IC87114 (C) cultured under
Th1- or Th2-inducing conditions for 3 days (B) or
for 3 and 6 days (C).
(D–F) Concentrations of IFN-g and IL-4 in the
supernatants measured by ELISA after naive
p85a+/ or p85a/ CD4+ T cells (D) or wt CD4+
T cells with or without IC87114 (E and F) were
differentiated for 3 days (D and E) or 6 days (F) as
described in (B) and (C) and restimulated for
overnight with immobilized anti-CD3ε Ab and
1 mg/ml soluble anti-CD28 Ab in fresh media
(n = 4). Error bars indicate SEM.
(G) Immunoblot analysis of T-bet, GATA3, and
Runx1/3. Naive CD4+ T cells were differentiated to
Th1 or Th2 cells for 2, 4, or 6 days (D) with or
without IC87114, and nuclear proteins were
examined by western blotting with the indicated
Abs.
Results are representative of more than three
independent experiments.
See also Figure S1.2008). In CD4+ T cells, PI3K-Akt axis augments the clonal expan-
sion of Th1 and Th2 cells (Arimura et al., 2004; Okkenhaug et al.,
2006).We report here that PI3K-Akt-mTORC1-S6K1/2 axis plays
a major role in the differentiation of Th17 cells through its regula-
tion of the expression of Gfi1 and the nuclear translocation of
RORg.
RESULTS
Class IA PI3K Activity Plays a Major Role in the
Differentiation of Th17 Cells
Stimulation of T cells through a combination of TCR/CD3 and
CD28 or ICOS induces the activation of PI3K followed by the
phosphorylation of Akt at Ser473 by mTORC2 and Thr308 by
PDK1 (Coyle et al., 2000; Lee et al., 2010). Indeed, plate-bound
anti-CD3ε antibody (Ab) induced the phosphorylation of Akt at
both Ser473 and Thr308 (Figure 1A). IC87114, a selective inhib-
itor for p110d, dampened the phosphorylation of both Akt
and S6K1, whereas rapamycin, anmTORC1 inhibitor, selectively
inhibited the phosphorylation of S6K1 without impairing the
phosphorylation of Akt (Figure 1A). Both the loss of p85a and
treatment with IC87114 also inhibited the activation of Akt under
conditions promoting the differentiation of Th1, 2, and 17 cells(see Figures S1A and S1B), suggesting that most PI3K activity
in differentiating CD4+ T cells can be ascribed to the p85a/
p110d heterodimer. In contrast to B cells (Suzuki et al., 2003),
expression of p110d was not significantly affected by the loss
of p85a in CD4+ T cells, possibly due to the high expression level
of p50a in T cells (Figures S1C and S1D). Although phosphoryla-
tion of Akt at Ser473 was impaired by PI3K inhibitors, the
mTORC2 activity evaluated by PKCq phosphorylation wasmain-
tained (Figure S1E). PI3K was required for the activation of Akt in
the early phase (15 min) of TCR stimulation, whereas the phos-
phorylation of Akt and its target Foxo1/3a was unchanged by
PI3K inhibitors in the later phase of stimulation (Figure S1E).
We then examined the effect of PI3K inhibition on Th differen-
tiation. The differentiation of Th1 or Th2 cells on days 3 and 6 of
culture (Figures 1B and 1C) and the production of lineage-
specific cytokines from these cells (Figures 1D–1F) were little
affected by the loss of p85a or by inhibiting p110d. Expression
of Th1- or Th2-associated transcription factors on days 2, 4,
and 6 was not affected by inhibiting p110d (Figure 1G). Contrary
to the Th1 and Th2 differentiation, both the loss of p85a and the
inhibition of p110d impaired the differentiation of Th17 cells
primed with IL-6 and TGF-b by 50%–60%, and this reduction
was unchanged by the addition of IL-21 and IL-23 (Figures 2ACell Reports 1, 360–373, April 19, 2012 ª2012 The Authors 361
Figure 2. The Class IA PI3K-Akt-mTORC1
Axis Positively Regulates Th17 Differentia-
tion
(A and B) Intracellular staining of IL-17A and IFN-g
in p85a+/ or p85a/ CD4+ T cells (A) or wt CD4+
T cells with or without IC87114 (B) cultured under
the indicated conditions for 3 days.
(C and D) Concentrations of IL-17A in the super-
natants after naive p85a+/ or p85a/ CD4+
T cells (C) or wt CD4+ T cells with or without
IC87114 (D) were cultured as described in (A) and
(B) and restimulated for overnight with immobilized
anti-CD3ε Ab and 1 mg/ml soluble anti-CD28 Ab in
fresh media (n = 4). Error bars indicate SEM.
(E) Intracellularstainingof theexpressionof IL-17Aand
IL-17F by CD4+ T cells cultured under Th17-inducing
conditions with or without IC87114 for 3 days.
(F) Intracellular staining of the expression of IL-17A
and IFN-g by CD4+ T cells expressing Akt-mer
cultured under the Th17-inducing conditions with
or without 4-HT and indicated inhibitors for 3 days.
(G) Concentrations of IL-17A in the supernatants
after Akt-mer tg or wt naive CD4+ T cells were
cultured under Th17-inducing conditions with indi-
cated reagents for 3 days and restimulated as des-
cribed in (C) and (D) (n = 3). Error bars indicate SEM.
Results are representative of more than three inde-
pendent experiments.
See also Figure S2.and 2B). Impaired Th17 differentiation was confirmed by the
reduced production of IL-17A (Figures 2C and 2D) and IL-17F
(Figure 2E) in the absence of p85a or by IC87114. These results
indicate that the activation of class IA PI3K is mostly involved in
the differentiation of Th17 cells.
We next examined the influence of forced activation of Akt
during the differentiation of Th17 cells using naive CD4+ T cells
from transgenic (tg) mice expressing Akt-mer, a chimeric protein
fusing Akt with a mutated estrogen receptor (mer) (Murayama
et al., 2007). In these T cells Akt can be artificially activated by
4-hydroxytamoxyfen (4-HT) (Figure S2A). As shown in Fig-362 Cell Reports 1, 360–373, April 19, 2012 ª2012 The Authorsure S2B, 4-HT alone did not affect the
differentiation ofwild-type (wt) Th17 cells.
Compared to Th17 cells derived from
untreated Akt-mer tg CD4+ T cells, 4-HT
treatment increased the percentage of
CD4+ T cells highly expressing IL-17A
(Figure 2F, IL-17Ahigh CD4+ T cells,
boxed). Productionof IL-17Aasexamined
by ELISA was also enhanced by 4-HT
treatment, and the impaired IL-17A
production by IC87114 was recovered
by 4-HT treatment in Akt-mer tg CD4+
T cells (Figure 2G). The increased propor-
tions of IL-17high CD4+ T cells and IL-17A
secretion with 4-HT treatment were
blocked by IC87114 and more severely
by rapamycin (Figures 2F and 2G). Intrigu-
ingly, Th17 cells expressing Akt-mer
coexpressed T-bet (Tbx21) and IFN-gupon treatment with 4-HT (Figures 2F and S2C–S2E). The differ-
entiation of Th1 or Th2 cells from naive CD4+ T cells expressing
Akt-mer was also augmented by 4-HT (data not shown), con-
sistent with the previous notion that activated Akt accelerates
CD4+ Th cell differentiation (Arimura et al., 2004).
Activation of mTORC1 Is Necessary for the
Differentiation of Th17 Cells
The observation that rapamycin inhibits Th17 differentiation in
both wt and Akt-mer tg CD4+ T cells strongly suggests the
involvement of mTORC1 in the process. Upon activation of
PI3K, Akt phosphorylates TSC1/2 complex, a negative regulator
of Rheb, resulting in the binding of Rheb tomTORC1and the acti-
vation ofmTORC1 (Wullschleger et al., 2006). As expected, rapa-
mycin strongly inhibited the differentiation of Th17 cells at low
doses, even in the presence of IL-21 and IL-23, whereas the
differentiation of Th1 cells was enhanced (Figures 3A and 3B).
Production of IL-17A by Th17 cells was also severely impaired
by rapamycin,whereas theamountof IFN-g secretedbyTh1cells
was not significantly affected (Figure 3C). Proliferation of both
Th1 and Th17 cells was similarly blocked by rapamycin in
a dose-dependent manner (Figure S3A). To confirm the impor-
tance of mTORC1 in Th17 differentiation, naive CD4+ T cells
from Raptorfl/fl mice or LckCreRaptorfl/fl mice were differentiated
into Th1 or Th17 cells. In accordance with the results with rapa-
mycin, Th17 cell differentiation in LckCreRaptorfl/fl CD4+ T cells
was significantly impaired compared to that in Raptorfl/fl CD4+
T cells, whereas the differentiation of Th1 cells in LckCreRaptorfl/fl
CD4+ T cells was improved (Figure 3D). In LckCreRaptorfl/fl mice
the number of CD4+ and CD8+ T cells in periphery was approxi-
mately half of thoseofLckCreRaptorfl/+mice,but the thymicdevel-
opment of T cells was normal, and the percentage of Foxp3+
T cells among CD4+ T cells was unchanged (data not shown).
To further confirm the role of mTORC1, we examined the
effect of forced activation of mTORC1 on Th17 differentiation
by transfecting a constitutively active form of Rheb (Rheb Q64L)
(Ohtani et al., 2008). Although the total percentage of Th17 cells
was unchanged by the expression of Rheb Q64L (45% without
transfection, 43% for control vector, and 42% for Rheb Q64L
expression vector), the percentage of IL-17Ahigh CD4+ T cells
was increased in the population expressing Rheb Q64L (GFP+)
(31%, brown) compared to those not expressing Rheb Q64L
(GFP) (21%, green) or those transfected with a control vector
(23%, red) (Figures 3E and 3F). These results collectively indicate
that mTORC1 plays a pivotal role in the differentiation of Th17
cells.
Because the importance of mTORC1 downstream of PI3K in
Th17 differentiation was suggested, we next examined the
activity of mTORC1 under distinct cytokine milieus. In addition
to IL-1b (Gulen et al., 2010), IL-2 and IL-6 also activate mTORC1
activation. However, mTORC1 activities examined by S6K1
phosphorylation were similar in Th0, Th1, Th2, and Th17 cells.
TGF-b suppressed the mTORC1 activity induced by IL-6 with
or without IL-2/IL-23 during Th17 differentiation (Figure S3B;
data not shown).
Rapamycin Attenuates Th17 Differentiation In Vivo
We next examined whether rapamycin also inhibits the differen-
tiation of Th17 cells in vivo using a murine CD4+ T cell transfer
model of colitis and an experimental autoimmune encephalomy-
elitis (EAE) model. The mTORC1 inhibitors rapamycin or everoli-
mus alleviate the severity of both EAE and colitis induced by
IL-10 deficiency (Donia et al., 2009; Matsuda et al., 2007), but
the influence of mTORC1 suppression on Th17 differentiation
in vivo during disease development has been obscure.
In the CD4+ T cell transfer model of colitis, the percentages of
IL-17A-producing cells among CD4+ T cells from the mesenteric
lymph nodes and spleens of rapamycin-treated mice were
significantly lower compared to PBS-treated mice 6 weeks afterthe initial transfer of CD4+CD25CD45RBhigh T cells, whereas
the percentages of IFN-g-producing cells were augmented in ra-
pamycin-treated mice (Figure 3G). Both PBS-treated and rapa-
mycin-treated Rag2/ mice developed watery stools around
3 weeks after the initial transfer, but rapamycin-treated mice
experienced less weight loss compared to controls (Figure 3H).
Both thickening of the colon wall and severe infiltration of mono-
nuclear cells were observed in the colons of PBS-treated mice
6 weeks after the cell transfer, and these histological changes
were alleviated by rapamycin treatment (Figure 3I). The weight/
length ratios of the colon, which correlates well with histopatho-
logical scores (Ostanin et al., 2009), were significantly lower in
mice treated with rapamycin compared to controls (Figure 3J).
Similar results were observed in the EAEmodel; clinical scores
of rapamycin-treatedmice were lower than those of PBS-treated
mice (Figure S3C), as shown before (Donia et al., 2009). As
observed in the CD4+ T cell transfer model of colitis, the percent-
ages of IL-17A-producing CD4+ T cells in draining lymph nodes
and spleens were decreased by rapamycin treatment (Fig-
ure S3D). However, the percentages of IFN-g-producing CD4+
T cells were unaffected in this diseasemodel (Figure S3D). These
results from two distinct in vivo models collectively demonstrate
that blockade of themTORC1 pathway decreases Th17 differen-
tiation in vivo.
Inhibition of the PI3K-Akt-mTORC1 Axis Fails to
Downregulate Gfi1 Expression during Th17
Differentiation
What are the molecular mechanisms by which the PI3K-Akt-
mTORC1 axis controls Th17 differentiation? Although the impor-
tance of STAT3 activation in Th17 differentiation has been
demonstrated (Yang et al., 2007), the phosphorylation of
STAT3 at Ser727 and Tyr705 was unaffected by the lack of
p85a or by the addition of IC87114 or rapamycin. This was true
during both the initial (30 and 90 min) and late (24 and 48 hr)
phases of Th17 differentiation (Figures S1D and S4A–S4D).
The phosphorylation of STAT3 at Tyr705 during Th17 differenti-
ation (48 hr) was also unchanged by deletion of raptor (Fig-
ure S4E). Correspondingly, the expression of IL-21, which
depends on STAT3 signaling (Nurieva et al., 2008), was unaf-
fected by the inhibition of the PI3K-Akt-mTORC1 axis
(Figure 4A).
We next examined the effect of inhibitors of the PI3K-Akt-
mTORC1 axis on the expression of various genes including
transcription factors during Th17 cell differentiation. As expected
from the results shown in Figures 2 and 3, both IC87114 and
rapamycin reduced the expression of Th17 cell-related genes
such as Il17a, Il17f, and Il23r. In contrast the expression of
Rora, Rorc, and Runx1 after 48 hr of Th17 cell differentiation
was unaffected by IC87114 (Figure 4A). Unexpectedly, rapamy-
cin enhanced the expression of Rorc and Runx1 (Figure 4A).
These inhibitors did not affect the expression of Foxp3 (Fig-
ure 4A). The expression of Foxp3 in Th17 or induced regulatory
T (iTreg) cells was attenuated by these inhibitors on day 1 but
was augmented by day 3 (Figures S4F and S4G). On day 5 the
differentiation of iTreg cells as assessed by Foxp3 expression
was significantly augmented by LY294002 or rapamycin but
not by IC87114 (Figure S4H) as previously reported (SauerCell Reports 1, 360–373, April 19, 2012 ª2012 The Authors 363
Figure 3. Activation of mTORC1 Is Required for Th17 Differentiation
(A and B) Intracellular staining of the expression of IL-17A and IFN-g (A) or IL-17A and IL-17F (B) by CD4+ T cells cultured under the indicated conditions with or
without rapamycin for 3 days.
(C) Concentrations of IFN-g and IL-17A in the supernatants after naive CD4+ T cells were cultured under the indicated conditionswith or without rapamycin for 3 days
and restimulated for overnight with immobilized anti-CD3ε Ab and 1 mg/ml soluble anti-CD28 Ab in fresh media (n = 4). Error bars indicate SEM. n.s., nonsignificant.
(D) Intracellular staining of IL-17A and IFN-g in Raptorfl/fl or LckCreRaptorfl/fl CD4+ T cells cultured under the indicated conditions for 3 days.
(E) Flow cytometry of the expression of GFP and IL-17A by CD4+ T cells transfected with the indicated vectors and cultured under Th17-inducing conditions for
3 days. The percentage of IL-17Ahigh cells among GFP and GFP+ populations is shown in bold boxes.
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et al., 2008). To directly examine the role of Foxp3 in Th17 differ-
entiation, we employed the scurfy mutant (Foxp3sf) mice lacking
the forkhead binding domain of Foxp3 required to inhibit IL-17
expression (Ichiyama et al., 2008). The differentiation of Th17
cells from naive scurfy mutant CD4+ T cells was still sensitive
to these inhibitors (Figure S4I). These results indicate that the
impaired Th17 cell differentiation resulting from the inhibition of
the PI3K-Akt-mTORC1 axis cannot be attributed to changes in
the expression of Rorc, Rora, Runx1, or Foxp3. IC87114 and
rapamycin did not inhibit the expression of Tbx21 and Ifng during
Th1 cell differentiation, either (Figure 4B), consistent with the
observations in Figure 1.
It has recently been found that Gfi1 negatively regulates Th17
differentiation without affecting Rorc expression, and the
expression of Gfi1 is downregulated under Th17 conditions by
TGF-b (Ichiyama et al., 2009; Zhu et al., 2009). The expression
level of Gfi1 at 48 hr of Th17 differentiation was unchanged in
the presence of IC87114 or rapamycin at either the mRNA (Fig-
ure 4C) or protein level (Figure 4D) compared to those of Th0
cells, suggesting that the downregulation of Gfi1 expression
during Th17 differentiation is dependent on the PI3K-Akt-
mTORC1 axis.
S6K1-Mediated Expression of EGR2 Suppresses Gfi1
Expression during Th17 Differentiation
EGR1 and EGR2 are transcription factors known to inhibit the
expression of Gfi1 by directly binding to its promoter (Laslo
et al., 2006). Furthermore, the expression of EGR1 (Sarker and
Lee, 2004) and EGR2 (Carnevalli et al., 2010) is regulated down-
stream of PI3K-Akt-mTORC1-S6K1 axis. Hence, we next exam-
ined the roles of EGR transcription factors in Th17 differentiation.
As expected, expression of EGR1 and EGR2 measured by
western blotting was impaired by IC87114 or rapamycin treat-
ment during Th17 differentiation (Figure 5A). Expression of
EGR3 was impaired by IC87114 treatment but unchanged by
rapamycin treatment (Figure 5A). Expression of EGR1 was de-
tected only in the early phase (4 hr) of differentiation, whereas
those of EGR2 and EGR3 were mainly detected in the later
phase (48 hr) of differentiation (Figure 5A), suggesting that
EGR2 plays a major role in Gfi1 expression. We thus lentivirally
transfected EGR2 to naive CD4+ T cells and induced Th17
differentiation. After 48 hr, Gfi1 mRNA was decreased and that
of Il17a mRNA was increased compared to those transfected
with control lentivirus, whereas there was no significant differ-
ence in the expression of Rorc mRNA between these cells
(Figure 5B).
Carnevalli et al. (2010) has shown the involvement of S6K1 in
the expression of EGR2 in adipocytes. We lentivirally transfected(F) The percentage of IL-17Ahigh cells in (E) is shown (n = 3). Error bars indicate S
(G) Representative flow cytometry of intracellular staining for IL-17A and IFN-g in
recipients 6 weeks after the transfer of CD4+CD25CD45RBhigh T cells with or w
(H) Body weights of Rag2/ recipients described in (G) (n = 6 each, *p < 0.05). E
(I) Histopathology of hematoxylin and eosin-stained colon tissues from Rag2/
without rapamycin treatment. Scale bars represent 200 mm. Results are represe
(J) The weight/length ratios of total colons harvested from the Rag2/ recipient
Results are representative of more than three independent experiments.
See also Figure S3.control vector or rapamycin-resistant, constitutively active form
of S6K1 (S6K1-CA; Schalm and Blenis, 2002) to naive CD4+
T cells and restimulated these cells for 24 hr. Expression of
EGR2 was markedly increased by the transfection of S6K1-CA,
whereas that of EGR3 was only moderately increased (Fig-
ure 5C). We next lentivirally transfected S6K1-CA to naive
CD4+ T cells and differentiated these cells into Th17 cells with
or without rapamycin treatment. As shown in Figure 5D, S6K1-
CA phosphorylated S6 in the presence of rapamycin. Transfec-
tion of S6K1-CA augmented Th17 differentiation in the absence
of rapamycin (59%–71%) and restored Th17 cell differentiation
of rapamycin-treated cells (36%–50%) (Figure 5D, right panel),
indicating the involvement of S6K1 in Th17 differentiation.
Correspondingly, transfection of Rheb Q64L or S6K1-CA to
CD4+ T cells further suppressed the expression of Gfi1 mRNA
and increased the expression of Il17a mRNA during Th17 differ-
entiation (Figure 5E). These data indicate the involvement of
S6K1 downstream of PI3K-Akt-mTORC1 axis in the positive
regulation of EGR2 expression, leading to the downregulation
of Gfi1 expression during Th17 differentiation.
The PI3K-Akt-mTORC1 Axis Controls the Nuclear
Localization of RORg
Whereas RORg is selectively expressed in Th17 cells among
CD4+ Th cells and is indispensable for the differentiation of this
subset (Ivanov et al., 2006), the inhibition of PI3K-Akt-mTORC1
axis did not block Rorc mRNA expression (Figure 4A). We thus
examined the role of the PI3K-Akt-mTORC1 axis in the posttran-
scriptional and/or posttranslational regulation of RORg. As
shown in Figure 6A, the amount of total RORg was moderately
decreased by both IC87114 and rapamycin, indicating the
involvement of translational control downstream of PI3K-Akt-
mTORC1 axis (Ma and Blenis, 2009). Compared to the decrease
in the total amount of RORg, we noticed that the amount of
nuclear RORg was more severely reduced by both IC87114
and rapamycin during Th17 differentiation (Figures 6B and 6C).
In contrast, the amount of Runx1 in the nucleus was unaffected
by these inhibitors. Levels of nuclear T-bet and GATA3 were
unaffected by these inhibitors during Th1 and Th2 differentiation,
respectively (Figure 6D). Because the nuclear translocation of
some transcription factors such as NF-ATc (Yang et al., 2008)
and IRF7 (Cao et al., 2008) is under the control of molecules
downstream of PI3K, we examined the influence of the suppres-
sion of the PI3K-Akt-mTORC1 axis on the nuclear translocation
of RORg. Immunofluorescence microscopy revealed that the
nuclear translocation of RORg after 18 hr of Th17 differentiation,
a peak time point of Rorc expression (Ivanov et al., 2006), was
impaired in the presence of IC87114 or rapamycin (Figures 6E,EM. n.s., nonsignificant.
CD4+ T cells from mesenteric lymph nodes (mLNs) or spleens of the Rag2/
ithout rapamycin treatment.
rror bars indicate SEM.
recipients 6 weeks after the transfer of CD4+CD25CD45RBhigh T cells with or
ntative of six mice each.
s described in (I) (n = 6). Error bars indicate SEM.
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Figure 4. Effects of IC87114 and Rapamycin on the Expression of
Transcription Factors
(A and B) Real-time PCR analysis of the indicated mRNA expression in CD4+
T cells cultured under the indicated conditions (Tfh, T follicular helper cells,
366 Cell Reports 1, 360–373, April 19, 2012 ª2012 The Authors6F, and S5A), whereas the percentage of RORg+ T cells was
unaffected by these inhibitors (Figure 6G). In contrast to RORg
the nuclear translocation of T-bet and GATA3 in Th1 and Th2-
inducing conditions, respectively, at 48 hr was unchanged by
IC87114 or rapamycin (Figures S5B and S5C). When inhibitors
for PI3K and mTORC1 were added to the culture on day 2 of
Th17 differentiation, nuclear translocation of RORg and Th17
differentiation were unaffected (Figures S5D and S5E), suggest-
ing that the PI3K-Akt-mTORC1 axis is critical for the early phase
of Th17 differentiation.
The nuclear localization of transcription factors is regulated
at two steps: import into the nucleus, and export from the
nucleus. The best-characterized molecule involved in the latter
mechanism is CRM1 (Wagstaff and Jans, 2009). We incubated
rapamycin-treated CD4+ T cells differentiating into Th17 cells
with leptomycin B, an inhibitor of CRM1, for the last 4 hr during
24 hr incubation. Although leptomycin B enhanced the nuclear
localization of ERK2, one of known CRM1-dependent proteins,
the impaired nuclear localization of RORg by rapamycin was
not restored by leptomycin B (Figure 6H). These results suggest
that the PI3K-Akt-mTORC1 axis plays an important role in the
nuclear import of RORg rather than export of RORg from the
nucleus.RORg Binds S6K2 to Enhance Its Nuclear Translocation
Downstream of PI3K-Akt-mTORC1 Axis
Finally, we examined the molecular mechanism underlying
RORg translocation into the nucleus downstream of the PI3K-
Akt-mTORC1 axis. Although many nuclear proteins possess
nuclear localization signal (NLS) that is recognized by importins
(Wagstaff and Jans, 2009), no functional NLS has been deter-
mined in RORg so far. We also estimated possible NLS
sequences in RORg using PredictProtein (Rost et al., 2004),
which revealed no possible NLS sequence in RORg (data not
shown).
It is known that cytoplasmic or nuclear proteins without NLS
can be transported into the nucleus by binding to other proteins
with functional NLS in a piggyback fashion (Wagstaff and Jans,
2009). Therefore, we searched for nuclear proteins with func-
tional NLS expressed in Th17 cells that can interact with RORg,
and found that S6K2, the nuclear-localized counterpart of S6K1
with functional NLS on its C terminus (Koh et al., 1999), bound
RORg. When HEK293T cells were cotransfected with Flag-
tagged RORg and Myc-tagged S6K2, the interaction of these30 ng/ml IL-6) with or without indicated inhibitors for 48 hr (n = 3). Error bars
indicate SEM.
(C)Gfi1 expression in CD4+ T cells cultured under the indicated conditions with
or without indicated inhibitors for 48 hr was examined by real-time PCR (n = 3).
Error bars indicate SEM.
(D) Immunoblot analysis of Gfi1 expression. Naive CD4+ T cells were cultured
under the indicated conditions with or without indicated inhibitors for 48 hr,
and whole-cell extracts were examined by western blotting with the indicated
Abs. The numbers indicate the relative band amount of Gfi1 protein in each
sample obtained by dividing the Gfi1 band intensity by the GAPDH band
intensity in each lane.
Results are representative of more than three independent experiments.
See also Figure S4.
Figure 5. EGR2 and Gfi1 Expressions Are
Regulated by S6K1 Downstream of PI3K-
Akt-mTORC1 Axis
(A) Immunoblot analysis of EGR1, EGR2, and
EGR3. Naive CD4+ T cells were cultured under the
indicated conditions with or without indicated
inhibitors for 4 or 48 hr. Whole-cell extracts were
examined by western blotting with the indicated
Abs.
(B) Real-time PCR analysis of the indicated mRNA
expression in CD4+ T cells transfected with control
or Egr2 lentivirus and cultured under the indicated
conditions for following 48 hr (n = 4). Error bars
indicate SEM.
(C) Immunoblot analysis of EGR2 and EGR3. Naive
CD4+ T cells were transfected with control or
S6K1-CA lentivirus and restimulated with immo-
bilized anti-CD3ε Ab and 1 mg/ml soluble anti-
CD28 Ab in fresh media for 24 hr. Whole-cell
extracts were examined by western blotting with
the indicated Abs.
(D) Left panels show immunoblot analysis of S6K1
or S6 phosphorylation with or without lentiviral
transfection of S6K1-CA and rapamycin treatment.
Naive CD4+ T cells were transfected with control
or S6K1-CA lentivirus and cultured under the
Th17-inducing conditions with or without rapamy-
cin for 3 days. Whole-cell extracts were examined
by western blotting with the indicated Abs. Right
panels illustrate flowcytometry of the expressionof
GFP and IL-17A by CD4+ T cells transfected
with the indicated vectors and cultured under
Th17-inducing conditions for 3 days. The per-
centages of IL-17A+ cells among GFP and GFP+
populations are shown in bold boxes.
(E) Real-time PCR analysis of the indicated mRNA
expression in CD4+ T cells transfected with
control, Rheb Q64L, or S6K1-CA lentivirus and
cultured under the indicated conditions for
following 48 hr (n = 4). Error bars indicate SEM.
Results are representative of more than three
independent experiments. n.s., nonsignificant.molecules was readily observed by coimmunoprecipitation
(Figures 7A and 7B). Importantly, the transfection of S6K2 to
HEK293T cells was able to enhance the nuclear localization ofCell Reports 1, 360–3transfected RORg (Figure 7C). These
results demonstrate the critical role of
S6K2 in the nuclear translocation of
RORg.
We next examined the kinetics of the
expression and nuclear localization of
S6K2 in CD4+ T cells. The interaction of
Flag-tagged RORg and Myc-tagged
S6K2 in HEK293T cells observed by
coimmunoprecipitation was not impaired
by rapamycin treatment (data not
shown), suggesting that these molecules
interacted independently of S6K2 phos-
phorylation by mTORC1. Interestingly,
the expression of S6K2 in CD4+ T cellswas increased during Th17 differentiation, which was impaired
by IC87114 or rapamycin treatment (Figure 7D). Because
expression of Rps6kb2 mRNA, encoding S6K2, was not73, April 19, 2012 ª2012 The Authors 367
Figure 6. Inhibition of the PI3K-Akt-mTORC1 Axis Impairs the Nuclear Translocation of RORg during Th17 Differentiation
(A) Immunoblot analysis of RORg in whole-cell lysates. Naive CD4+ T cells were cultured under the indicated conditions with or without indicated inhibitors for
18 hr. Whole-cell extracts were examined by western blotting with the indicated Abs.
(B) Immunoblot analysis of RORg. Naive CD4+ T cells were cultured under Th0- or Th17-inducing conditions with or without indicated inhibitors for 18 hr. Left
panels show nuclear fractions of naive CD4+ or naive CD8+ cells and cultured Th0 or Th17 cells that were examined by western blotting. Right panels illustrate
cytoplasmic and nuclear fractions of cultured Th0 or Th17 cells that were examined for the expression of RORg.
(C) The ratio of nuclear/cytoplasmic RORg band amount. Western blotting was performed as described in the right panels of (B), and the ratio was obtained by
dividing the nuclear RORg band intensity normalized with the TBP band intensity by the cytoplasmic RORg band intensity normalized with the GAPDH band
intensity in each lane (n = 3). Error bars indicate SEM.
(D) Immunoblot analysis of T-bet, GATA3, or RORg expression. Naive CD4+ T cells were cultured under the indicated conditions with or without indicated
inhibitors for 48 hr, and nuclear fractions were examined by western blotting.
(E) Immunofluorescence microscopic analyses of RORg distribution in CD4+ T cells in the absence or presence of IC87114 or rapamycin after cultivation for 18 hr
under Th17-inducing conditions.
(F) The frequencies of the cells with RORg localized in the nucleus or cytoplasm among RORg+CD4+ T cells in (E) were calculated (n = 3). Error bars indicate SEM.
(G) The frequencies of RORg+ cells among CD4+ T cells in (E) were calculated (n = 3). Error bars indicate SEM.
(H) Effect of leptomycin B on the localization of RORg and ERK2 in the cytoplasm and nucleus. Naive CD4+ T cells were cultured under Th0- or Th17-inducing
conditions with or without 3 nM rapamycin for 18 hr. Leptomycin B (200 nM) was added for the last 6 hr. Cytoplasmic or nuclear fractions of cultured Th0 or Th17
cells were examined for the expression of RORg and ERK2.
Results are representative of more than three independent experiments.
See also Figure S5.
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Figure 7. S6K2 Interacts with RORg and Enhances Its Nuclear Translocation
(A and B) Coimmunoprecipitation of RORg and S6K2. HEK293T cells were transfected with the indicated cDNAs and cultured for 24 hr. Whole-cell lysates were
prepared, and immunoprecipitation was performed using anti-Flag Ab (A) or anti-Myc Ab (B). Immunoprecipitates were examined by western blotting.
(C) Immunoblot analysis of Flag-tagged RORg and Myc-tagged S6K2 in the cytoplasm or nucleus. HEK293T cells were transfected with indicated vectors for
24 hr, and cytoplasmic and nuclear fractions of these cells were examined by western blotting. The numbers indicate the relative band intensities of RORg-Flag
protein in each sample obtained by dividing the cytoplasmic or nuclear RORg-Flag band intensity by the GAPDH or TBP band intensity, respectively.
(D) Immunoblot analysis of S6K2 in whole-cell lysates. Naive CD4+ T cells were cultured under the indicated conditions with or without indicated inhibitors for
48 hr. Whole-cell extracts were examined by western blotting with the indicated Abs. The relative band intensity of S6K2 protein obtained by dividing the S6K2
band intensity by the GAPDH band intensity in each lane is shown in the right panel (n = 3). Error bars indicate SEM.
(E) Real-time PCR analysis of the Rps6kb2mRNA expression in CD4+ T cells cultured under the indicated conditions with or without indicated inhibitors for 48 hr
(n = 3). Error bars indicate SEM. n.s., nonsignificant.
(F) Immunoblot analysis of S6K2 in the cytoplasm or nucleus. Naive CD4+ T cells were cultured under the indicated conditions with or without indicated inhibitors
for 48 hr. Cytoplasmic and nuclear fractions of these cells were examined by western blotting with the indicated Abs.
Results are representative of more than three independent experiments.influenced by these inhibitors during Th17 differentiation (Fig-
ure 7E), this S6K2 inhibition may be due to posttranscriptional
regulation such as control of S6K2 translation or degradation
downstream of PI3K-Akt-mTORC1. S6K2 was mainly localized
in the nucleus in CD4+ T cells as well (Figure 7F), and the
amount of nuclear S6K2 was also increased during Th17 differ-
entiation, which was impaired by both IC87114 and rapamycin
(Figure 7F).
DISCUSSION
The PI3K pathway is important in T cell proliferation following
stimulation through the TCR and costimulatory molecules
such as CD28 and ICOS (Coyle et al., 2000; Okkenhaug et al.,
2006). Furthermore, the PI3K-Akt axis generally increases the
Th cell differentiation (Arimura et al., 2004). Indeed, forced Akt
activation using Akt-mer tg mice increased differentiation of allTh cell subsets. However, the specific role of PI3K within each
Th cell subset has been unclear. As demonstrated here, the
PI3K-Akt-mTORC1 axis is important for Th17 differentiation,
whereas initial differentiation of Th1 and Th2 cells does not
depend on the activation of class IA PI3K. Impaired Th1 and
Th2 differentiation from p110dD910A/D910A CD4+ T cells has
been shown both in vivo and in vitro (Okkenhaug et al., 2006).
However, CD4+ T cells used in that study include nTregs, which
could affect Th differentiation from naive CD4+ T cells. Although
the phosphorylation of Akt at Ser473 as well as of Foxo1/3a
is impaired by deletion of p85a or PI3K inhibitors, this does
not mean the inhibition of mTORC2, which is required for Th1
and Th2 differentiation (Lee et al., 2010), because the phosphor-
ylation of another mTORC2 target PKCq is maintained as shown
here. Rather, the impaired phosphorylation of Akt at both
Ser473 and Thr308 is attributed to the impaired membrane
recruitment of Akt due to the inhibition of PI3K and theCell Reports 1, 360–373, April 19, 2012 ª2012 The Authors 369
reduced production of phosphatidylinositol-(3,4,5)-trisphos-
phate (Andjelkovic et al., 1997). Interestingly, PI3K activation
is required for Akt and Foxo1/3a phosphorylation during the
early phase of CD4+ T cell activation, whereas in the later phase
these molecules are phosphorylated equally with or without
PI3K inhibition, which supports the notion that Akt can be acti-
vated by both PI3K-dependent and -independent pathways
(Franke et al., 2003). This would explain why Th1 and Th2 differ-
entiation is unaffected by p85a deletion or PI3K inhibition,
although Foxo transcription factors are critical for the suppres-
sion of Th1 and Th2 differentiation (Lin et al., 2004). Kinetics of
T-bet and Gata3 induction in Th1 and Th2 differentiation are
slower than that of RORg in Th17 differentiation, which would
enable Th1 and Th2 cells to escape the inhibitory effects
of PI3K suppression and enhanced Foxo1/3a activity in the early
phase of differentiation.
Downstream of PI3K, mTOR forms complexes with raptor
or rictor, called mTORC1 or mTORC2, respectively. PI3K
mainly activates mTORC1 via the activation of Rheb, and rapa-
mycin selectively suppresses the activity of mTORC1 (Wulls-
chleger et al., 2006). Much attention has been given to mTORC1
in the immune system because this molecule is involved in the
generation of Foxp3+ regulatory T (Treg) cells. Consistent with
the previous study (Sauer et al., 2008), the expression of
Foxp3 on day 3 of Th17 or iTreg differentiation was augmented
by LY294002 or rapamycin, but not by IC87114. Interestingly,
the expression of Foxp3 was differentially regulated by PI3K-
Akt-mTORC1 axis at different time points. The expression of
Foxp3 during Th17 or iTreg differentiation was impaired on day
1 but unchanged on day 2. The reason why inhibition of PI3K-
Akt-mTORC1 axis impaired the initial expression of Foxp3 is
unclear. Based on a previous study demonstrating that Foxp3
binds to RORg and impairs its function (Zhou et al., 2008), it is
possible that the suppression of PI3K-Akt-mTORC1 axis
enhances Foxp3 expression, which impairs Th17 differentiation.
However, CD4+ T cells from Foxp3sf mice are still sensitive to
IC87114 or rapamycin, indicating that the regulation of Th17
differentiation by PI3K-Akt-mTORC1 axis is independent of
Foxp3 expression. Furthermore, because the selective inhibition
of p110d by IC87114 does not increase Foxp3 expression on
day 3 of Th17 differentiation, or because the inhibition of Th17
differentiation by rapamycin can be observed on day 2 of
differentiation when Foxp3 expression is not increased, the
augmentation of Foxp3 expression cannot explain our observa-
tions that Th17 differentiation is suppressed by the inhibition of
PI3K-Akt-mTORC1 axis.
Our study sheds light on Gfi1 instead of Foxp3 as a key mole-
cule regulating Th17 differentiation through the PI3K-Akt-
mTORC1 axis. The downregulation of Gfi1 and Gfi1 protein is a
critical event for Th17 differentiation (Ichiyama et al., 2009; Zhu
et al., 2009), which is impaired by IC87114 or rapamycin. The
expression of Gfi1 is blocked by EGR2 during hematopoiesis
(Laslo et al., 2006), and the expression of EGR2 is positively
regulated downstream of mTORC1 and S6K1 in adipocytes
(Carnevalli et al., 2010). We showed here similar regulatory
mechanisms during Th17 differentiation. Specifically, thePI3K-
Akt-mTORC1-S6K1 axis induces EGR2, which downregulates
the expression of Gfi1 and increases Th17 differentiation.370 Cell Reports 1, 360–373, April 19, 2012 ª2012 The AuthorsEGR1 is also regulated downstream of PI3K-Akt-mTORC1 axis
and a possible candidate to inhibit Gfi1 expression downstream
of this axis (Laslo et al., 2006). However, the expression of EGR1
is transient and is restricted to the very early stage of Th cell
differentiation.
Another mechanism blocking Th17 differentiation upon
inhibition of the PI3K-Akt-mTORC1 axis is impaired nuclear
translocation of RORg. Although the total amount of RORg is
moderately decreased by inhibition of PI3K-Akt-mTORC1
pathway, possibly because of the translational control down-
stream of this axis (Ma and Blenis, 2009), the involvement of
regulation in the nuclear translocation is also evident because
the amount of nuclear RORg is severely reduced, whereas the
amount of cytoplasmic RORg is unchanged by the inhibition of
this axis. A CRM1 inhibitor leptomycin B did not restore the
impaired nuclear localization of RORg by rapamycin, indicating
that PI3K-Akt-mTORC1 axis contributes to the nuclear translo-
cation rather than exportation of RORg. There is a precedent
for a role of the PI3K-Akt-mTORC1 axis in the nuclear transloca-
tion of transcription factors: the phosphorylation and nuclear
translocation of IRF7 in plasmacytoid dendritic cells are
controlled by the PI3K-Akt-mTORC1 axis (Cao et al., 2008).
Nuclear transport of NF-ATc is also regulated by the PI3K-Akt-
mTORC1 axis because mTORC1 phosphorylates NF-ATc at
Ser168 andSer 170 (Yang et al., 2008). IRF7 andNF-ATcpossess
functional NLS, and the phosphorylation of IRF7 results in its
dimerization and retention in the nucleus (Marie´ et al., 2000),
whereas changes in phosphorylation status in NF-ATc unmask
its NLS (Yang et al., 2008); however, RORg neither dimerizes
nor possesses NLS. Instead, we demonstrated that RORg inter-
acts with S6K2, which possesses a functional NLS at its C
terminus (Koh et al., 1999), andS6K2enhances the nuclear trans-
location of RORg in a piggyback fashion. PI3K-Akt-mTORC1 axis
enhances the expression of S6K2 and, thus, accelerates the
nuclear translocation of RORg during Th17 differentiation.
Because Th17 cells contribute to the development of chronic
inflammatory disorders (Ouyang et al., 2008), it would be useful
to suppress Th17 differentiation by modulating the PI3K-Akt-
mTORC1 axis for the treatment of such diseases. As shown in
this study as well as by others (Donia et al., 2009; Matsuda
et al., 2007), suppression of mTORC1 by intraperitoneal admin-
istration of rapamycin alleviated the severity of symptoms in both
the CD4+ T cell transfer model of colitis and in EAE. It has been
shown that both IL-17 and IL-23 are required for the develop-
ment of EAE (McGeachy et al., 2009). Similarly, the expression
of Rorc (Leppkes et al., 2009) and Il23r (Yen et al., 2006) is an
important step in the development of colitis, but IL-17 alone
exerts a protective effect in the CD4+ T cell transfer model of
colitis (O’Connor et al., 2009). Therefore, the attenuated severity
in the CD4+ T cell transfer model of colitis upon treatment with
rapamycin observed in our study would be attributed to the
impaired nuclear translocation of RORg and suppression of
Il23r expression.
In summary the PI3K-Akt-mTORC1-S6K1/2 axis positively
regulates Th17 differentiation via its effects on the suppression
of Gfi1 expression and on the nuclear translocation of RORg.
The manipulation of this axis would thus be applicable to the
treatment of chronic inflammatory diseases involving Th17 cells.
EXPERIMENTAL PROCEDURES
Reagents
Antibodies used in this study are described in Extended Experimental
Procedures. IC87114 and LY294002 were purchased from Symansis and
Calbiochem, respectively. Rapamycin, PMA, ionomycin, and 4-HT were
purchased from Sigma-Aldrich. Brefeldin A was purchased from eBioscience.
Mice
All animal experiments were performed in accordance with protocols
approved by the Animal Care and Use Committee of the Keio University and
were performed in accordance with the institutional guidelines. C57BL/6
mice were purchased from Japan SLC. p85a+/ or p85a/ mice on a
BALB/c or C57BL/6 background were described previously (Fukao et al.,
2002; Suzuki et al., 2003), and Rag2/ mice on a C57BL/6 background
were obtained from Taconic. Raptorfl/fl mice on a C57BL/6 background have
been established by a standard method, and detailed characterization will
be described elsewhere (T.H. and A.H., unpublished data). Akt-mer tg mice
on a C57BL/6 background (Murayama et al., 2007) were kindly provided by
T. Nakano (Osaka University, Osaka, Japan). OT-IIxRag2/xFoxp3sf mice
(scurfy mice) on a C57BL/6 background were generous gifts from S. Hori
(RCAI, RIKEN, Yokohama, Japan). All mice were maintained in our SPF animal
facilities, and 6- to 10-week-old mice were used for all experiments unless
otherwise stated.
Isolation of Naive CD4+ T Cells
CD4+CD25CD62Lhigh T cells (naive CD4+ T cells) were purified from spleno-
cytes using a CD4+CD62L+ T cell isolation kit II (Miltenyi Biotec, purity: >95%)
according to the manufacturer’s protocol except that biotin-conjugated anti-
mouse CD45RB Ab (BD PharMingen) and streptavidin microbeads (Miltenyi
Biotec) were used for the secondary positive sorting for the isolation of
CD4+CD25CD45RBhigh T cells.
Cell Culture
RPMI1640 (Sigma-Aldrich) supplementedwith 10% fetal calf serum (HyClone),
50 mM 2-mercaptoethanol, 100 U/ml penicillin, 100 mg/ml streptomycin,
nonessential amino acids, 1 mM sodium pyruvate, and 10 mM HEPES was
used as a complete culturemedium.MACS purified CD4+ T cells were cultured
in 96-well plates (2.0 3 105 cells per well) and were stimulated with immobi-
lized anti-CD3ε Ab (plates coated with 5 mg/ml anti-CD3ε Ab in 100 ml PBS)
and 1 mg/ml soluble anti-CD28 Ab. Culture medium was supplemented with
10 ng/ml IL-12 for Th1 differentiation, 10 ng/ml IL-4 for Th2 differentiation,
3 ng/ml TGF-b for Treg differentiation, or 30 ng/ml IL-6 and 3 ng/ml TGF-b
for Th17 differentiation. In several experiments, 50 ng/ml IL-21 and 10 ng/ml
IL-23 were further added to the culture medium for the differentiation of
Th17 cells. IC87114, LY294002, rapamycin, and 4-HT are used at 2 mM,
2 mM, 3 nM, and 2 mM, respectively.
Intracellular Staining of Cytokines and Transcription Factors
Cells were stimulated with 50 ng/ml PMA, 1 mM ionomycin and 3 mg/ml brefel-
din A for 4 hr, and intracellular cytokine staining was performed using IntraPrep
(Beckman Coulter) according to the manufacturer’s protocol. A PE
anti-mouse/rat Foxp3 staining kit (eBioscience) was used for the intracellular
staining of Foxp3. Flow cytometry was performed on a FACSCalibur (BD
Biosciences), and data were analyzed using FlowJo Software (Tree Star).
Quantitative Real-Time PCR
Total RNA was extracted using NucleoSpin RNA II (Macherey-Nagel). cDNA
was reverse transcribed using a High Capacity RNA-to-cDNA Master Mix
(Applied Biosystems) according to the manufacturer’s protocol. A CFX96
Real Time PCRSystem, C1000 Thermal Cycler, and Sso Fast EvaGreen super-
mix (all from Bio-Rad) were used to evaluate gene expression. The expression
level of each gene was normalized to Gapdh expression. The primers for Rora
(Yang et al., 2008), Rorc and Il23r (Ivanov et al., 2006), Gfi1 (Ichiyama et al.,
2009), and Tbx21 and Gata3 (Yang et al., 2007) were previously described.
Other primer sequences are described in Table S1.ELISA
A total of 1million cells/ml Th1, 2, or 17 cells was restimulated with immobilized
anti-CD3ε Ab and 1 mg/ml soluble anti-CD28 Ab for overnight in fresh media.
Concentrations of IFN-g, IL-4, and IL-17A in culture supernatants were de-
tected with Quantikine Colorimetric Sandwich ELISA (R&D Systems) accord-
ing to manufacturer’s instructions.
SDS-PAGE and Western Blotting
SDS-PAGE and western blotting analyses including a S6K1 band-shift assay
were performed as previously described (Ohtani et al., 2008). Nuclear proteins
and cytoplasmic proteins were separately extracted by NE-PER Nuclear and
Cytoplasmic extraction Reagents (Pierce, Rockford, IL, USA). ECL Advance
Western Blotting Detection Kits (GE Healthcare) or Western Lightning Plus
kits (PerkinElmer) were used for the detection of chemiluminescence. An
LAS-3000 imaging system (Fuji film) was used to quantitate digital images.
Anti-GAPDH Ab was used as a loading control for whole-cell lysate and cyto-
plasmic proteins. Anti-TBP (TATA binding protein) Ab was used as a loading
control for nuclear proteins.
Statistical Analysis
Mean and SEM values were calculated from at least three independent exper-
iments, and p values were calculated using a two-tailed unpaired Student’s
t test.
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